Moderna and Merck said on Tuesday their experimental personalized vaccine continued to cut the risk of death or recurrence of ...

Dow Jones Top Company Headlines at 11 AM ET: Moderna, Merck Report Positive Results From Cancer-Vaccine Study | D.R. ... Moderna and Merck's cancer vaccine reduced the risk of relapse or death for ...

Moderna and Merck's cancer vaccine reduced the risk of relapse or death for melanoma patients. "Moderna, Merck Report ...

A personalized cancer treatment developed by Moderna Inc. and Merck & Co. helped prevent the recurrence of high-risk skin ...

Moderna and Merck’s cancer vaccine reduced the risk of relapse or death for melanoma patients, five-year data from a Phase 2b ...

Invesco Equity and Income Fund lagged its benchmark in Q4 2025 as IT and fixed income weighed. See new holdings and full ...

Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced a multi-year collaboration with Merck, known as MSD outside the United States and Canada, to support the ...

Discover methods for accessing company earnings reports and earnings calls. Use the SEC's EDGAR system and Nasdaq to stay informed about financial performance.

Having this war chest serves two major purposes. The first is that Berkshire Hathaway is earning billions on the $305 billion ...

The original is 6 stories and holds 1,500 cars: the new one is only 4 stories and 500 cars,” said Merck spokesman Greg Landis.

BOSTON, Jan. 15, 2026 /PRNewswire/ -- TetraScience, the Scientific Data and AI company, today announced the appointment of Matt Studney as Chief Customer Officer. Studney is a seasoned business, R&D, ...

Illumina unveiled the Billion Cell Atlas, a large‑scale genetic perturbation dataset built with pharma partners to advance AI‑powered drug discovery, target validation, and disease biology.